AI solution for Digital Breast Tomosynthesis
Lunit INSIGHT DBT is the commercial name of Lunit INSIGHT MMG 2.0
Less Doubts,
More Confidence
Location of suspicious lesions (soft tissue lesions and calcification) marked with abnormality scores
Global Partners
Bringing Our World-Class AI to 3D
Lunit INSIGHT MMG(2D)'s Proven Performance
The First AI Used for a National Screening Program
Lunit INSIGHT MMG(2D) has been selected for Australia’s national breast screen
program to assist radiologists in examining 350,000 women per year.
First Prospective Study Validating the
Clinical Impact of Lunit INSIGHT MMG(2D) in a Real-World Screening
Setting
The clinical trial conducted on 55,759 women in a
prospective screening setting showed that Lunit INSIGHT
MMG(2D), working with a single radiologist, detected more
breast cancers compared to a team of two radiologists.
Best Performing Algorithm,
Lunit INSIGHT MMG(2D), Validated by External Evaluation
Lunit INSIGHT MMG (2D) showed the best accuracy
in breast cancer detection compared to other commercial
algorithms.
Features
Read with Confidence
Lunit INSIGHT DBT quantifies the likelihood of malignancy for each
suspicious lesion with an abnormality score (0-100%) and
displays location information with heatmap or contours.
It also provides information on lesion types:
soft tissue lesions (mass, architectural distortion, and asymmetry)
& calcification.
Read with Convenience
Lunit INSIGHT DBT supports various integration types
(SR, SC, GSPS, and In-App Viewer).
It enables you to click and jump to the best visible slice
(SR and In-app viewer).
Read Faster
Lunit INSIGHT DBT not only highlights each lesion for greater visibility,
but also presents the best 3D slice best to show a suspicious lesion
which accelerates tomo reading.